MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can early chemo before surgery stop colon Cancer's return?
Disease control Not yet recruitingThis study aims to find the best timing for chemotherapy in people with high-risk colon cancer. It will compare giving four cycles of chemotherapy before surgery versus having surgery first followed by standard chemotherapy. The main goal is to see if the 'chemo first' approach h…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Donor immune cells join fight against advanced throat cancer
Disease control Not yet recruitingThis trial is testing whether adding donor immune cells called Natural Killer (NK) cells to standard chemotherapy and radiation can reduce cancer recurrence in patients with advanced nasopharyngeal cancer. The study will first find the safest dose of these donor cells, then test …
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New blood test could predict liver Cancer's return after surgery
Diagnosis Not yet recruitingThis study is testing a new blood test that detects tiny amounts of leftover cancer cells after liver cancer surgery. Researchers want to see if this test can better predict which patients' cancer will return and identify who might benefit from additional immunotherapy treatment.…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 09, 2026 14:22 UTC